Finch Therapeutics
In Seth Klarman's portfolio · Baupost Group
Ticker FNCH
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Baupost Group 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2024 | Sell | 0 | |
| Q4 2023 | No change | 67,296 | 0.0% |
| Q3 2023 | No change | 67,296 | 0.0% |
| Q2 2023 | Reduce 97% | 67,296 | 0.0% |
| Q1 2023 | Add 98% | 2,019,008 | 0.0% |
| Q4 2022 | Reduce 9% | 1,019,008 | 0.0% |
| Q3 2022 | No change | 1,123,108 | 0.0% |
| Q2 2022 | No change | 1,123,108 | 0.0% |
| Q1 2022 | Reduce 1% | 1,123,108 | 0.1% |
| Q4 2021 | Reduce 6% | 1,132,253 | 0.1% |
| Q3 2021 | No change | 1,208,159 | 0.1% |
| Q2 2021 | No change | 1,208,159 | 0.1% |
| Q1 2021 | Buy | 1,208,159 | 0.2% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.